![Separator Separator](https://www.ceoinsightsindia.com/images/line.png)
How Reformed is the Healthcare Industry?
![Separator Separator](https://www.ceoinsightsindia.com/images/line.png)
![How Reformed is the Healthcare Industry? How Reformed is the Healthcare Industry?](https://www.ceoinsightsindia.com/uploaded_images/newstransfer/xr2h0.sujith.jpg)
Sujith Vasudevan, Managing Editor, 0
Technological advancements have been the most significant change. The pandemic forced the
implementation of many technologies and innovations, which were just a part of the conversation other wise. COVID-19 made the industry think about the similar healthcare catastrophes ahead of us and how to be prepared to face such predicaments, hence the increasing focus on approaches like Immunomodulatory therapy.
Talking to CEO Insights magazine, Sanjay Vyas, EVP, Global SBU Head-Clinical Logistics & Global Safety Services & Managing Director India, Parexel, explains it aesthetically, “The methodology used in some of the vaccines today, such as Messenger RNA (mRNA), is an excellent example of the application of technology. Conventional vaccines use a dead virus, what we call the unaffected virus, to transmit the vaccine into the body so that our body becomes immune to the whole process. But with the mRNA, a virus is no longer required to be a part of that vaccine. On the other hand, if it took around 5-7 years to launch a conventional vaccine or a therapy in the market, it has been reduced to less than two years.” It’s a great time to be in the healthcare industry, with many challenges and opportunities.
Talking to CEO Insights magazine, Sanjay Vyas, EVP, Global SBU Head-Clinical Logistics & Global Safety Services & Managing Director India, Parexel, explains it aesthetically, “The methodology used in some of the vaccines today, such as Messenger RNA (mRNA), is an excellent example of the application of technology. Conventional vaccines use a dead virus, what we call the unaffected virus, to transmit the vaccine into the body so that our body becomes immune to the whole process. But with the mRNA, a virus is no longer required to be a part of that vaccine. On the other hand, if it took around 5-7 years to launch a conventional vaccine or a therapy in the market, it has been reduced to less than two years.” It’s a great time to be in the healthcare industry, with many challenges and opportunities.